Author

Rachel P. Wallace

University of ChicagoORCID 0000-0003-4439-1173Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

Ani SolankiiD· 2 shared Aaron Esser-Khan· 1 shared Aaron T. AlpariD· 1 shared Abigail L. LauterbachiD· 1 shared Anna J. SlezakiD· 1 shared Derek Elli· 1 shared Dominique M. MissiakasiD· 1 shared Duy-Thuc NguyeniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ani SolankiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJan 24, 2026

Polymer-lipid hybrid nanoparticle enhances mRNA delivery and T cell-mediated immunity

Xiaolei Cai, Min Chen, Guoshuai Cao…·Jun Huang

This study develops a polymer-lipid hybrid nanoparticle (PLNP) to enhance mRNA delivery and T cell immunity, showing improved antigen-specific T cell responses and protection against viral variants and cancer.

1 citation

multiomeexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintMar 21, 2024

Engineered Flt3L Drives Tolerogenic State to Attenuate Anti-drug Antibody Responses

Aaron T. Alpar, Rachel P. Wallace, Kirsten C. Refvik…·Jeffrey A. Hubbell

The paper describes a method using engineered Flt3L to induce a tolerogenic immune state, reducing anti-drug antibodies to a fungal enzyme.

DOI 10.1101/2024.03.21.586168

humanproteomics

𝕏 PostBluesky